Abstract
The induction of the phase II drug-metabolizing enzyme, NAD(P)H:quinone reductase (QR), using Hepa 1c1c7 hepatoma cells, is currently used as a key member of a panel of in vitro bioassays in our program directed towards the discovery of new plantderived cancer chemopreventive agents. Among a group of natural products, which have been studied as QR inducers are the withanolides, which constitutes about 400 C28 ergostane-type steroids found mainly in approximately 10 genera of the plant family Solanaceae. New withanolides have been isolated and characterized in our recent work on Physalis philadelphica (tomatillo), which is used as a vegetable and condiment in Mexican and Central American cuisine. A further study on Deprea subtriflora has led to the discovery of a new class of C-18 norwithanolides with only 27 carbons in their skeleton. Preliminary structure-activity relationships have been determined for the in vitro induction of QR by members of the withanolide and norwithanolide classes.
Keywords: enzyme, carbons, (tomatillo), hepatoma
Mini-Reviews in Organic Chemistry
Title: Induction of the Phase II Enzyme, Quinone Reductase, by Withanolides and Norwithanolides from Solanaceous Species
Volume: 1 Issue: 1
Author(s): Bao-Ning Su, Jian-Qiao Gu, Young-Hwa Kang, Eun-Jung Park, John M. Pezzuto and A. Douglas Kinghorn
Affiliation:
Keywords: enzyme, carbons, (tomatillo), hepatoma
Abstract: The induction of the phase II drug-metabolizing enzyme, NAD(P)H:quinone reductase (QR), using Hepa 1c1c7 hepatoma cells, is currently used as a key member of a panel of in vitro bioassays in our program directed towards the discovery of new plantderived cancer chemopreventive agents. Among a group of natural products, which have been studied as QR inducers are the withanolides, which constitutes about 400 C28 ergostane-type steroids found mainly in approximately 10 genera of the plant family Solanaceae. New withanolides have been isolated and characterized in our recent work on Physalis philadelphica (tomatillo), which is used as a vegetable and condiment in Mexican and Central American cuisine. A further study on Deprea subtriflora has led to the discovery of a new class of C-18 norwithanolides with only 27 carbons in their skeleton. Preliminary structure-activity relationships have been determined for the in vitro induction of QR by members of the withanolide and norwithanolide classes.
Export Options
About this article
Cite this article as:
Su Bao-Ning, Gu Jian-Qiao, Kang Young-Hwa, Park Eun-Jung, Pezzuto M. John and Kinghorn Douglas A., Induction of the Phase II Enzyme, Quinone Reductase, by Withanolides and Norwithanolides from Solanaceous Species, Mini-Reviews in Organic Chemistry 2004; 1 (1) . https://dx.doi.org/10.2174/1570193043488926
DOI https://dx.doi.org/10.2174/1570193043488926 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Emerging Anabolic Treatments in Osteoporosis
Current Drug Safety Endoscopic Microscopy Using Optical Coherence Tomography
Current Medical Imaging The Production of Solid Dosage Forms from Non-Degradable Polymers
Current Pharmaceutical Design Theranostic Aspects: Treatment of Cancer by Nanotechnology
Mini-Reviews in Medicinal Chemistry A Hopeful Prospect of Riociguat as a Soluble Guanylate Cyclase Stimulator for Management of Pressure Ulcers
Current Drug Discovery Technologies Integrins as Novel Drug Targets for Overcoming Innate Drug Resistance
Current Cancer Drug Targets Polyphenols: A Nutraceutical Approach Against Diseases
Recent Patents on Food, Nutrition & Agriculture Arginine Deprivation as a Targeted Therapy for Cancer
Current Pharmaceutical Design Aromatase Inhibitors and Inactivators for the Treatment of Postmenopausal Breast Cancer: A Review
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Synthesis and Biological Activity of Some New N1-(4-oxoquinolin-6-yl) amidrazones
Letters in Organic Chemistry LOH12CR1 is a Novel Tumor Suppressor Inhibiting Tumor Growth Through Deregulation of G1/S Checkpoint in Human Colorectal Carcinoma
Current Molecular Medicine Integrins: Novel Therapeutic Targets for Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Combating P-glycoprotein-Mediated Multidrug Resistance Using Therapeutic Nanoparticles
Current Pharmaceutical Design The Place of Somatostatin Analogs in the Diagnosis and Treatment of the Neuoroendocrine Glands Tumors
Recent Patents on Anti-Cancer Drug Discovery Polycistronic Viral Vectors
Current Gene Therapy Update of QSAR & Docking Studies of the GSK-3 Inhibitors
Current Bioinformatics Experimental Model Considerations for the Study of Protein-Energy Malnutrition Co-Existing with Ischemic Brain Injury
Current Neurovascular Research Harnessing the Capacity of Cell-Penetrating Peptides for Drug Delivery to the Central Nervous System
Current Pharmaceutical Biotechnology Mitochondrial Uncoupling and the Regulation of Glucose Homeostasis
Current Diabetes Reviews Synthetic Lethal Interactions in Cancer Therapy
Current Cancer Drug Targets